No Data
LANCANG TEA: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE ANNUALREPORT AND USE OF PROCEEDS FROM LISTING
Announcement Highlights | China Life Insurance issued 35 billion capital supplementary bonds; Zheng Zhigang resigned as the President of New World Development.
HSBC has completed the issuance of Hong Kong's first private digital bond, with a total amount of 1 billion Hong Kong dollars; junshi bio's JS125 has obtained a drug clinical trial approval letter.
Lancang Ancient Tea (06911): has submitted the H股 full circulation record filing to the China Securities Regulatory Commission.
Lancang Ancient Tea (06911) announced that on September 26, 2024, the company has submitted relevant documents to the China Securities Regulatory Commission...
LANCANG TEA: 2024 INTERIM REPORT
Performance: Lan Cang ancient tea (06911.HK) reported a net profit of 5.09 million RMB for the first half of the year, a decrease of 79.1% and no dividend will be distributed.
Lancang Ancient Tea (06911.HK) announced its interim performance for the six months ending in June, with revenue of 0.195 billion RMB, a year-on-year decrease of 15.9%. Recorded a net profit of 5.09 million yuan, a decline of 79.1%, with earnings per share of 6 cents. No interim dividend declared.
Lancang Ancient Tea (06911.HK) reported a mid-term revenue of 0.195 billion yuan, a year-on-year decrease of 15.9%.
On August 26, Greelong Hui announced that the group's operating revenue in mid-2024 was 19.51 million RMB, with a net profit attributable to company owners of 5.1 million RMB, a decrease of 15.9% and 79.1%, respectively, compared to the same period in 2023. The decline in the company's operating performance is due to both slow recovery in terminal consumer demand and intensified industry competition leading to a decrease in the group's operating revenue. Additionally, the group's investment in brand promotion and product sales has increased, resulting in an overall increase in sales expenses for the group.
No Data
No Data